Pulmonx Corporation (LUNG) vs Nutriband Inc. (NTRB)

A side-by-side comparison of Pulmonx Corporation and Nutriband Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LUNG vs NTRB

growth of $100 · dividends reinvested · last 5y
LUNG -95.1% (-45.2%/yr)NTRB +30.1% (+5.4%/yr)NTRB compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$5$130
LUNG NTRB

LUNG vs NTRB: by the numbers

  • •NTRB is the larger company ($81M vs $80M market cap).
  • •Both run net losses; LUNG's is the smaller (-55.03% vs -430.43% net margin).
  • •LUNG grew revenue faster over the past five years (15.86% vs 3.12% CAGR).

Metrics side by side

Valuation

MetricLUNGNTRB
Forward P/EN/A4.26
P/S ratio0.9150.31
P/B ratio2.0415.28

Profitability

MetricLUNGNTRB
Gross margin77.06%33.14%
Operating margin-52.96%-408.41%
Net margin-55.03%-430.43%
ROE-122.76%-130.67%
ROIC-48.39%-126.99%

Growth (annualized)

MetricLUNGNTRB
Revenue CAGR (5Y)15.86%3.12%
Total return CAGR (5Y)-45.30%6.67%

Frequently asked

Which has grown faster, LUNG or NTRB?
Over the past five years, LUNG grew revenue faster — LUNG at a 15.86% CAGR versus NTRB at 3.12%.
How have LUNG and NTRB total returns compared?
Over the past 5 years, LUNG delivered -45.30% and NTRB delivered 6.67% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.